Awareness Program Intellectual Property Rights in Biopharmaceuticals

Events

On March 9, 2022
[et_pb_dcsbcm_divi_breadcrumbs_module separator="sep-tilde" _builder_version="4.6.1" _module_preset="default" body_font="Open Sans||||||||" fontsseparator_font="||||||||" fontsseparator_font_size="12px" fontsbreadcrumblinks_font="Open Sans||||||||" custom_padding="5px||5px||true|false" hover_enabled="0" body_font_size="15px" sticky_enabled="0"][/et_pb_dcsbcm_divi_breadcrumbs_module]

About the Programme:

The course will give knowledge aboutIntellectual Property Rights in Biopharmaceuticals.

IPR provides incentives for drug manufacturers to invest in the development of new and innovative drugs, leading to advances in medicine and improved patient outcomes. IPR helps to ensure the quality and safety of drugs by providing a legal framework for the protection and enforcement of intellectual property rights, preventing the production and distribution of counterfeit or substandard drugs.

IPR can facilitate the transfer of technology and knowledge between different countries, allowing for the development of new drugs in areas with limited resources.

IPR can ensure equitable access to medicines by promoting the development and distribution of drugs to areas with unmet medical needs, including developing countries.

Overall, the outcomes of IPR in biopharmaceuticals can have significant and far-reaching impacts on the development, availability, and affordability of drugs, as well as on the health and well-being of patients and society as a whole.

Objectives of the program:

  • To provide exclusive rights to the inventor of a new drug, IPR encourages investment in research and development, leading to the creation of new and innovative drugs.
  • To provide a mechanism for recovering the costs of research and development, this can be substantial for biopharmaceuticals.
  • To encourage competition among drug manufacturers by granting exclusive rights to the inventor or creator for a limited period of time, after which the drug becomes available for generic production.
  • To ensure the inventor of a drug has the exclusive right to produce, market, and profit from the drug, protecting their investment in research and development.
  • To promote the transfer of technology and knowledge between different countries, allowing for the development of new drugs in areas with limited resources.

Topics to be covered:

  • IPR in biopharmaceuticals
  • Trademarks
  • Copyrights
  • Trade secrets
  • Licensing agreements
  • Regulatory exclusivity
  • Infringement
  • International agreements and regulations

Programme Committee:

Chief Patron

Chairman

Dr. P. Rajeshwar Reddy,

M.Sc, Ph.D.

Secretary and Correspondent

Patron

Dr. M. Chinna Eswaraiah,

M. Pharm, Ph.D.

Principal

Convener

Mr. K. Raveendra Babu

M. Pharm,

Assistant Professor

Department of Pharmacy Practice

Email ID: ravipharma36@gmail.com

Contact number: 99592 12028

Coordinator

Mr. T. Praveen Kumar

M. Pharm,

Assistant Professor,

Department of Pharmaceutics,

Email ID: praveensuri1@gmail.com

Contact number: 9100337332

Resource Person:

Dr. S. MS Nikhil,

Department of Pharmacy Practice,

Vikas College of Pharmaceutical Sciences, Suryapet, Telangana.

Email ID: sms.nikhil123@gmail.com

Contact number: 9866353620

Address for Communication:

Mr. T. Praveen Kumar

M. Pharm,

Assistant Professor,

Department of Pharmaceutics,

Email ID: praveensuri1@gmail.com

Contact number: 9100337332

Last date to Registration: 02/03/2022

Related Articles

0 Comments

Submit a Comment

Your email address will not be published. Required fields are marked *